12 September 2018
Having established the first drug to selectively target cancer cells, Imatinib, Dr. Brian Druker is heralded as a pioneer in the field of precision medicine. Here, Druker shares his personal motivation to study cancer, what it takes to reach a breakthrough, and how today’s technology is accelerating us towards the future of cancer therapy.